Article citationsMore>>

Herbst, R.S., Eckhardt, S.G., Kurzrock, R., et al. (2010) Phase I Dose-Escalation Study of Recombinant Human Apo2l/Trail, a Dual Proapoptotic Receptor Agonist, in Patients with Advanced Cancer. Journal of Clinical Oncology, 28, 2839-2846.
https://doi.org/10.1200/JCO.2009.25.1991

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top